Current Science

Open Access Open Access  Restricted Access Subscription Access

Repurposing Anti-Tuberculosis and Anti-Leprosy Vaccine Against COVID-19 Disease: An Indian Experience


Affiliations
1 Department of Biochemistry, Room 3020, AII India Institute of Medical Sciences, New Delhi 110 029, India
2 Department of Health Research, Ministry of Health and Family Welfare, Government of India, New Delhi 110 001, India
3 Talwar Research Foundation, E-6&8, NEB Valley, Neb Sarai, New Delhi 110 068, India
 

No Abstract.

Keywords

No Keywords.
User
Notifications
Font Size

  • https://www.worldometers.info/coronavirus/#countries

  • http://www.bcgatlas.org/index.php

  • Brook, B. et al., Sci. Transl. Med., 2020, 12, pii:eaax4517; doi:10.1126/scitranslmed.aax4517.

  • Goodridge, H. S. et al., Nat. Rev. Immunol., 2016, 16, 392–400.

  • Desai, N. M. and Khamar, B. M., N. Engl. J. Med., 2014, 371, 2533–2534.

  • Sehgal, I. S. et al., Lung India, 2020, 37, 279–281.

  • http://www.pharmabiz.com/NewsDetails.aspx?aid=123751&sid=1

  • https://pib.gov.in/PressReleasePage.aspx?PRID=1616379


Abstract Views: 338

PDF Views: 128




  • Repurposing Anti-Tuberculosis and Anti-Leprosy Vaccine Against COVID-19 Disease: An Indian Experience

Abstract Views: 338  |  PDF Views: 128

Authors

Ruby Dhar
Department of Biochemistry, Room 3020, AII India Institute of Medical Sciences, New Delhi 110 029, India
Babban Jee
Department of Health Research, Ministry of Health and Family Welfare, Government of India, New Delhi 110 001, India
Gursaran Pran Talwar
Talwar Research Foundation, E-6&8, NEB Valley, Neb Sarai, New Delhi 110 068, India
Subhradip Karmakar
Department of Biochemistry, Room 3020, AII India Institute of Medical Sciences, New Delhi 110 029, India

Abstract


No Abstract.

Keywords


No Keywords.

References





DOI: https://doi.org/10.18520/cs%2Fv119%2Fi7%2F1078-1079